相关实验视频
Updated: Jun 21, 2025

09:17
Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
21.6K
黄类物质菲塞丁可以降低痴呆症的多种生理风险因素
1Salk Institute for Biological Studies, La Jolla, CA, 92037, USA.
Neurochemistry international
|July 14, 2024
概括
菲塞是一种天然化合物,在对抗痴呆症风险因素方面表现有前途. 动物研究表明,它有保护大脑和解决多种风险的潜力,提供了一种新的治疗途径.
科学领域:
- 神经科学是一个神经科学.
- 老年学是一门学科.
- 药理学 药理学是指药理学的学科.
背景情况:
- 由于人口老龄化,全球痴呆症的患病率正在增加.
- 痴呆症存在可修改的风险因素,但个体治疗带来了诸如多药学等挑战.
- 针对多种风险因素的单一化合物可以提供更安全的替代方案.
研究的目的:
- 审查弗拉沃诺尔菲塞丁作为治疗痴呆症风险因素的治疗剂的潜力.
- 探索菲塞丁对各种痴呆相关风险的疗效及其神经保护性质.
主要方法:
- 审查现有的关于菲塞和痴呆症风险因素的科学文献.
- 对动物研究的分析,证明了菲塞对危险因素和神经保护的影响.
主要成果:
- 菲塞丁在动物模型中已经证明对多重痴呆症风险因素的有效性.
- 菲西具有与痴呆症预防相关的直接神经保护作用.
- 该化合物具有减轻与衰老和痴呆相关风险的潜在策略.
结论:
- 菲塞显示出作为一种多位治疗药物,在降低痴呆风险方面具有显著的潜力.
- 进一步的人类临床试验是有必要的,以验证fisetin在人类中的有效性和安全性.
- 菲塞丁可能为同时管理多个痴呆症风险因素提供了一个有希望的替代方案.
相关概念视频
Dementia
110
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
110
Alzheimer's Disease: Treatment
177
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
177

